Shoubao Ma

City Of Hope National Medical Center — United States

Immunology and Microbiology · Life Sciences

11h-index608citations39works2.72yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(31), Immunotherapy and Immune Responses(20), Cancer Immunotherapy and Biomarkers(16), CAR-T cell therapy research(9), IL-33, ST2, and ILC Pathways(9)

Publications39 total

Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy

Cancer Research·2026Open Access

Natural killer cell immunotherapies beyond cancer

Cell investigation.·2025Open Access

Loss of YTHDF2 enhances Th9 programming and CAR-Th9 cell antitumor efficacy

4 cited

Nature Immunology·2025· 4 cited

Natural killer cell–based immunotherapy for cancer

14 cited

The Journal of Immunology·2025· 14 citedOpen Access

924 Disruption of m6A reader protein YTHDF2 enhances Th9 cell differentiation and potentiates the anti-tumor efficacy of CAR Th9 cells

Regular and Young Investigator Award Abstracts·2024Open Access

Reduction of myeloid‐derived suppressor cells in prostate cancer murine models and patients following white button mushroom treatment

12 cited

Clinical and Translational Medicine·2024· 12 citedOpen Access

Supplementary Table S1 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Table S1 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S3 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S1 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S5 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S6 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S2 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S5 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Data from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Data from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

Supplementary Figure S4 from Preclinical Evaluation of Off-The-Shelf PD-L1+ Human Natural Killer Cells Secreting IL15 to Treat Non–Small Cell Lung Cancer

2024Open Access

page 1 of 2Next →

Frequent Co-authors

Jianhua Yu(36), Michael A. Caligiuri(31), Ting Lu(24), Jianying Zhang(24), Anthony G. Mansour(22), Kun‐Yu Teng(21), Hanyu Chen(20), Christian Bustillos(18), Rui Ma(17), Zhiyao Li(17), Zhenlong Li(17), Miguel A. Villalona‐Calero(17), Lei Tian(5), Zhiyao Li(4), Sai Jin Xiao(4), Zheng Zhu(3), Zhenlong Li(3), Rui Ma(3), Bethany L. Mundy-Bosse(3), Bin Zhang(2)